isomethyleugenol has been researched along with Tauopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, H; Li, X; Lu, C; Meng, L; Shi, Q; Tang, S; Wang, X; Wei, L; Wu, B; Xiao, D; Xu, Y; Yang, X; Zhang, N; Zou, Y | 1 |
| Hudson, PR; McCaddon, A | 1 |
2 other study(ies) available for isomethyleugenol and Tauopathies
| Article | Year |
|---|---|
Methionine-Mediated Protein Phosphatase 2A Catalytic Subunit (PP2Ac) Methylation Ameliorates the Tauopathy Induced by Manganese in Cell and Animal Models.
Topics: Animals; Cell Line, Tumor; Cognitive Dysfunction; Hippocampus; Male; Manganese; Manganese Poisoning; Methionine; Methylation; Mice; Protein Phosphatase 2; Rats; Rats, Sprague-Dawley; Tauopathies | 2020 |
Methylation and phosphorylation: a tangled relationship?
Topics: Age Factors; Alzheimer Disease; Biomarkers; Cysteine; Folic Acid; Humans; Methylation; Phosphorylation; S-Adenosylhomocysteine; tau Proteins; Tauopathies | 2007 |